Abstract
Methods: Eighteen patients with SSc with unintentional weight loss and GI symptoms were consented and recruited. Nutrition symptomology (abridged Patient Generated Subjective Global Assessment), GI symptoms (UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tracker), health-related quality of life (CDC HRQOL), anthropometrics, diet (24-hour recall) and body composition (dual energy x-ray absorptiometry) were assessed at baseline and 6 weeks following MNT that emphasized greater caloric intake, improved protein distribution and texture alterations. Descriptive statistics (frequencies, means standard deviations), T-tests and c2 tests were conducted.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
